Ladenburg Thalmann Financial Services’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio CORV Stock Details CORV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-2,500	Closed	-$20K	–	4880
2015 Q4	$20K	Hold	2,500	–	–	﹤0.01%	3241
2015 Q3	$21K	Hold	2,500	–	–	﹤0.01%	3082
2015 Q2	$24K	Hold	2,500	–	–	﹤0.01%	3123
2015 Q1	$23K	Hold	2,500	–	–	﹤0.01%	3107
2014 Q4	$23K	Hold	2,500	–	–	﹤0.01%	2908
2014 Q3	$22K	Hold	2,500	–	–	﹤0.01%	2609
2014 Q2	$20K	Hold	2,500	–	–	﹤0.01%	2676
2014 Q1	$20K	Buy	2,500 +1,500	+150%	+$12.1K	﹤0.01%	2592
2013 Q4	$6K	Buy	+1,000	New	+$5.24K	﹤0.01%	3198

Other funds holding CORV

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

CCP

Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

AIS

AlphaOne Investment Services West Chester, Pennsylvania $79.5M AUM 49.42% 1-Year Est. Return

Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ladenburg Thalmann Financial Services's CORV Position: Q1 2016 in Review

Ladenburg Thalmann Financial Services sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q1 2016, closing a stake of 2,500 shares — an estimated $20K sold.

Ladenburg Thalmann Financial Services first reported a position in CORV in Q4 2013 and held it in 9 quarters. The position peaked at $24K in Q2 2015. 26 funds tracked by Wall St. Rank hold CORV as of Q1 2016.

Ladenburg Thalmann Financial Services reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q1 2016 after selling out during the quarter.
Ladenburg Thalmann Financial Services sold 2,500 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q1 2016, an estimated $20K.
Ladenburg Thalmann Financial Services first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q4 2013 and held it in 9 quarters.
Ladenburg Thalmann Financial Services's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $24K in Q2 2015.
26 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q1 2016.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q1 2016, filed 16 May 2016.